help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Méhes, G.
Right arrow Articles by Ambros, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Méhes, G.
Right arrow Articles by Ambros, P. F.
(American Journal of Pathology. 2001;159:17-20.)
© 2001 American Society for Investigative Pathology


Short Communications

Circulating Breast Cancer Cells Are Frequently Apoptotic

Gábor Méhes*, Armin Witt{dagger}, Ernst Kubista{dagger} and Peter F. Ambros*

From the Children’s Cancer Research Institute,*
St. Anna Kinderspital, Vienna; and the Department of Special Gynecology,{dagger}
Vienna General Hospital, Vienna, Austria

Automatic search for cytokeratin/mucin-1 double immunofluorescence was performed to detect and characterize circulating epithelial tumor cells in patients with advanced breast cancer. The peripheral blood samples in 8 of 19 patients (42.1%) presented with cytokeratin-positive and epithelial-type mucin-positive (CK+/MUC1+) tumor cells. Detailed microscopic analysis, however, suggested that the majority of the double immunopositive cells was apoptotic according to an "inclusion type" cytokeratin staining pattern and nuclear condensation. Furthermore, apoptosis-related DNA strand breaks could be demonstrated by applying the TdT-uridine nick end labeling assay in these cells. In 3 of 8 positive samples all of the CK+/MUC1+ cells displayed apoptotic features. We conclude that apoptotic cells significantly contribute to the circulating tumor cell fraction in breast cancer patients. As the predictive value of such cells for the outcome of the disease is unclear, they should be considered separately when analyzing tumor cell dissemination.





This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Z. Liu, M. Jiang, J. Zhao, and H. Ju
Circulating Tumor Cells in Perioperative Esophageal Cancer Patients: Quantitative Assay System and Potential Clinical Utility
Clin. Cancer Res., May 15, 2007; 13(10): 2992 - 2997.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. Lacroix
Significance, detection and markers of disseminated breast cancer cells
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
V. Pitini, C. Arrigo, C. Amata, and I. La Torre
Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes
Ann. Onc., November 1, 2005; 16(11): 1845 - 1845.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Muller, N. Stahmann, S. Riethdorf, T. Rau, T. Zabel, A. Goetz, F. Janicke, and K. Pantel
Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity
Clin. Cancer Res., May 15, 2005; 11(10): 3678 - 3685.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. J. Allard, J. Matera, M. C. Miller, M. Repollet, M. C. Connelly, C. Rao, A. G. J. Tibbe, J. W. Uhr, and L. W. M. M. Terstappen
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
Clin. Cancer Res., October 15, 2004; 10(20): 6897 - 6904.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A M Gilbey, D Burnett, R E Coleman, and I Holen
The detection of circulating breast cancer cells in blood
J. Clin. Pathol., September 1, 2004; 57(9): 903 - 911.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Pantel, V. Muller, M. Auer, N. Nusser, N. Harbeck, and S. Braun
Detection and Clinical Implications of Early Systemic Tumor Cell Dissemination in Breast Cancer
Clin. Cancer Res., December 15, 2003; 9(17): 6326 - 6334.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Wiedswang, E. Borgen, R. Karesen, G. Kvalheim, J.M. Nesland, H. Qvist, E. Schlichting, T. Sauer, J. Janbu, T. Harbitz, et al.
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
J. Clin. Oncol., September 15, 2003; 21(18): 3469 - 3478.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. L. Scaife, J. Kuang, J. C. Wills, D. B. Trowbridge, P. Gray, B. M. Manning, E. J. Eichwald, R. A. Daynes, and S. K. Kuwada
Nuclear Factor {kappa}B Inhibitors Induce Adhesion-dependent Colon Cancer Apoptosis: Implications for Metastasis
Cancer Res., December 1, 2002; 62(23): 6870 - 6878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. W. Wong, C. Song, M. M. Grimes, W. Fu, M. W. Dewhirst, R. J. Muschel, and A.-B. Al-Mehdi
Intravascular Location of Breast Cancer Cells after Spontaneous Metastasis to the Lung
Am. J. Pathol., September 1, 2002; 161(3): 749 - 753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.